Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis

BACKGROUND: Previous studies reported worsened lipid profiles in patients infected with hepatitis C virus (HCV) during direct-acting antivirals (DAAs) treatment. This study aimed to investigate the effect of sofosbuvir (SOF)-based DAAs on changes in low-density lipoprotein (LDL) in HCV patients. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying-Wen, Lee, Wei-Ping, Huang, Yi-Hsiang, Hou, Ming-Chih, Lan, Keng-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454153/
https://www.ncbi.nlm.nih.gov/pubmed/34548026
http://dx.doi.org/10.1186/s12879-021-06657-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454153/
https://www.ncbi.nlm.nih.gov/pubmed/34548026
http://dx.doi.org/10.1186/s12879-021-06657-9

Ejemplares similares